Device Trial Radar · NCT06628115
Post Market Study of Cerament V/G in Pedal Osteomyelitis
Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Oct 1, 2024
Primary completion
Aug 1, 2026
Study completion Aug 1, 2026
Sponsor
- Lead sponsor
- Mid and South Essex NHS Foundation TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- BONESUPPORT AB
- First posted
- Oct 4, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to look at the outcomes of patients who have had bone infection of their feet treated with a licensed antibiotic paste. The main question it aims to answer is: • How does the bone infection heal in response to the antibiotic paste? Participants will: * Undergo standard surgery to remove dead bone and drain any pus. * Antibiotic paste is injected directly into the middle of the bone at surgery. This is instead of receiving antibiotics directly into their bloodstream for 6 weeks. * Recieve one week of tablet antibiotics. * Visit clinic 1 month after surgery for a normal clinical appointment. After, a research team member will ask the participant a few questions. The participant will also have a foot x-ray, wound photograph and fill out a short questionnaire. * Visit clinic 6 months and 12 months following the surgery. A research team member will ask the participant a few questions. The participant will also have a foot x-ray, wound photograph and fill out a short questionnaire.
Conditions
- Osteomyelitis - Foot
Interventions
cerament V or GDevice
Cerament V or G implantation into forefoot or mid foot bone, and 7-10 days of oral antibiotics.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from clinical or radiological osteomyelitis in the same or adjacent bone (recorded as yes or no)Time frame: 12 months post-implantion
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mid and South Essex NHS Foundation Trust
Basildon, Essex, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.